WATSCO, INC. (WSO) capitalization

Current snapshot

Market Cap
$13.81B
38.0M shares × $363.79 · as of last filing 2026-03-31
Net Worth
$2.76B
Stockholders' equity · 2026-03-31
Enterprise Value
$13.59B
Market cap + debt − cash
Net Debt
-$224.2M
Debt $368.5M − Cash $592.7M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $12.77B
FY'24 2024-12-31 $17.78B
FY'23 2023-12-31 $15.65B
FY'22 2022-12-31
FY'21 2021-12-31 $11.08B
FY'20 2020-12-31 $7.96B
FY'19 2019-12-31 $6.25B
FY'18 2018-12-31 $4.78B
FY'17 2017-12-31 $5.59B
FY'16 2016-12-31 $4.83B
FY'15 2015-12-31 $3.80B
FY'14 2014-12-31 $3.46B
FY'13 2013-12-31 $3.10B
FY'12 2012-12-31 $2.38B
FY'11 2011-12-31 $2.02B
FY'10 2010-12-31 $1.93B
FY'10 2009-12-31 $1.40B
FY'10 2008-12-31

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $13.81B
Q4'25 2025-12-31 $12.77B
Q3'25 2025-09-30 $15.33B
Q2'25 2025-06-30
Q1'25 2025-03-31 $19.24B
Q4'24 2024-12-31 $17.78B
Q3'24 2024-09-30 $18.53B
Q2'24 2024-06-30
Q1'24 2024-03-31
Q4'23 2023-12-31 $15.65B
Q3'23 2023-09-30
Q2'23 2023-06-30
Q1'23 2023-03-31
Q4'22 2022-12-31
Q3'22 2022-09-30
Q2'22 2022-06-30
Q1'22 2022-03-31
Q4'21 2021-12-31 $11.08B
Q3'21 2021-09-30
Q2'21 2021-06-30 $10.16B
Q1'21 2021-03-31 $9.21B
Q4'20 2020-12-31 $7.96B
Q3'20 2020-09-30 $8.21B
Q2'20 2020-06-30 $6.23B
Q1'20 2020-03-31 $5.53B
Q4'19 2019-12-31 $6.25B
Q3'19 2019-09-30 $5.89B
Q2'19 2019-06-30 $5.64B
Q1'19 2019-03-31 $4.93B
Q4'18 2018-12-31 $4.78B
Q3'18 2018-09-30 $6.13B
Q2'18 2018-06-30 $6.13B
Q1'18 2018-03-31 $6.21B
Q4'17 2017-12-31 $5.59B
Q3'17 2017-09-30 $5.27B
Q2'17 2017-06-30 $5.04B
Q1'17 2017-03-31 $4.68B
Q4'16 2016-12-31 $4.83B
Q3'16 2016-09-30 $4.60B
Q2'16 2016-06-30 $4.59B
Q1'16 2016-03-31 $4.38B
Q4'15 2015-12-31 $3.80B
Q3'15 2015-09-30 $3.85B
Q2'15 2015-06-30 $4.02B
Q1'15 2015-03-31 $4.08B
Q4'14 2014-12-31 $3.46B
Q3'14 2014-09-30 $2.79B
Q2'14 2014-06-30 $3.32B
Q1'14 2014-03-31 $3.23B
Q4'13 2013-12-31 $3.10B
Q3'13 2013-09-30 $3.04B
Q2'13 2013-06-30 $2.71B
Q1'13 2013-03-31 $2.71B
Q4'12 2012-12-31 $2.38B
Q3'12 2012-09-30 $2.44B
Q2'12 2012-06-30 $2.35B
Q1'12 2012-03-31 $2.28B
Q4'11 2011-12-31 $2.02B
Q3'11 2011-09-30 $1.57B
Q2'11 2011-06-30 $2.09B
Q1'11 2011-03-31 $2.14B
Q4'10 2010-12-31 $1.93B
Q3'10 2010-09-30 $1.70B
Q2'10 2010-06-30 $1.76B
Q1'11 2010-03-31
Q4'10 2009-12-31 $1.40B
Q3'10 2009-09-30
Q2'10 2009-06-30

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (WSO CIK 0000105016), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

LNC

LINCOLN NATIONAL CORPORATION

TARS

TARSUS PHARMACEUTICALS, INC.

CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE